Artificial Intelligence (AI) is now a big part of healthcare technology. It helps with diagnosing, treating, and watching patients. AI-driven medical devices have changed how clinics work by making tasks more accurate and faster. But using AI in medical devices also brings questions about who is responsible if things go wrong. While many rules are made in Europe, especially with the updated Product Liability Directive (PLD), it is important for medical practice managers, owners, and IT staff in the United States to understand these changes. They need to be ready for new rules about liability and safety that might affect how they use AI medical devices.
The European Union recently changed its Product Liability Directive (PLD). This law says when manufacturers or others are legally responsible for injuries caused by defective products. The new PLD now includes software and AI systems used in medical devices. This means if an AI program inside a medical device malfunctions, it is treated the same as a physical product defect.
This change means more people can be held responsible, not just the hardware makers. It now includes those who develop, change, sell, or represent AI software. Manufacturers have to watch the whole life of the AI device, which might last up to 25 years. They need to make sure the software is updated, safe, and meets rules. If someone is hurt because the software had a problem that could have been fixed with an update, the manufacturer can be held responsible. This rule is stricter than before.
The PLD also allows people to claim damages for psychological harm and data loss. This is important because AI handles sensitive patient data and can affect treatment.
In the United States, similar AI medical devices are being used more widely. So, watching the European PLD changes can help U.S. medical practices understand global trends. Manufacturers often work internationally. Rules in Europe might influence U.S. laws or court cases, especially as AI-related lawsuits start to happen in America.
The U.S. Food and Drug Administration (FDA) has not made a special law just for AI product liability yet. But it has given more guidance and rules for AI medical devices. From 2017 to 2019, the FDA approved over 40 AI medical devices for clinical use. In 2024, the FDA recalled more than 60 AI devices due to safety problems. This shows AI in healthcare is growing fast and creating challenges for regulation.
In the U.S., manufacturers are usually liable if their medical device is unsafe because of design, making errors, or poor warnings. This is called product defect law. AI software has often been seen more like a tool to help decisions, not a medical device itself. Doctors are considered the last step to warn patients and make choices about AI advice. This idea limits manufacturer liability.
But court cases show this is changing. For example, in 2020, the Lowe v. Cerner case allowed the idea that software design problems in a hospital system could cause patient harm. In 2023, the Sampson v. HeartWise case pointed out the need for clear contract agreements between AI makers, healthcare providers, and device makers about who is responsible.
These cases show more attention to AI risks. Manufacturers are now advised to keep checking risks during design and after the AI device is in use. AI can change itself after it is put on the market. This creates new questions about responsibility when AI updates may cause harm.
One big problem is AI systems often work alone and are very complex. AI like deep neural networks act as a “black box.” They give results without showing how they got there. This makes it hard for doctors and courts to tell if the AI advice was good or fair.
Doctors still have to be careful and check AI advice before using it for patients. But AI can act in ways not planned by its creators. This makes it hard to decide who is at fault. Laws usually need human control and the chance to foresee problems. AI’s independent actions make these ideas harder to use.
Some legal experts suggest new ideas, like giving AI systems “personhood” so they can be held responsible or must have insurance. Others suggest “common enterprise liability,” meaning everyone who worked on the AI shares responsibility. These ideas are not in use yet but show how hard the problem is.
Manufacturers are not the only ones responsible for AI safety. Hospitals and clinics share some responsibility. They must train staff to use AI well, keep software updated, and check AI results carefully.
If a hospital does not support staff or fails to update the AI, it could be held responsible if mistakes happen. Doctors can be sued for malpractice if they use AI advice without thinking carefully.
This means responsibility is shared between AI makers, healthcare organizations, and doctors. Working together well can lower risks.
AI is not just used for diagnosing or treatment. It also helps with administrative tasks like answering phone calls. AI systems can schedule appointments, answer patient questions, and do basic triage before sending calls to staff.
For medical offices, AI automation can save money, save time, and make patients happier. But mistakes in these systems can cause problems. If AI makes errors that delay care or give wrong information, this can lead to liability.
Makers of AI front-office tools must make sure their software is reliable and follows privacy laws like HIPAA. They also need to have humans check for errors. Practices using these AI tools should train staff to watch the AI and have backup plans for problems.
Using AI in both clinical and office work changes who is responsible. Digital tools powered by AI are part of patient care and communication and must work carefully or they could cause harm.
Medical offices should do the following to reduce risks with AI medical devices and software:
The Product Liability Directive now clearly includes AI software in medical devices. This change means manufacturers are expected to keep AI safe throughout the product’s life and be open about risks. Even though these rules started in Europe, they affect manufacturers and healthcare providers in the U.S.
Medical practice managers, owners, and IT staff in the U.S. should watch these changes carefully. By knowing about manufacturer duties, clinical liability, and how AI fits into daily work—including front-office automation—they can better manage risks and offer safe patient care with AI help.
The main liability challenges include determining accountability for harm caused by AI, ensuring a legal framework that supports innovation while allowing claims from injured parties, and balancing responsibilities among stakeholders such as healthcare professionals, organizations, and producers.
In Europe, existing liability regimes cover personal injury risks through national contract and tort law and the Product Liability Directive (PLD), ensuring accountability among stakeholders while promoting innovation.
Notified Bodies have regulatory duties to ensure the safety of medical technologies, including AI, and may be held liable if they violate these obligations, leading to potential claims under general tort law.
The PLD establishes a strict liability regime for medical technologies, ensuring that manufacturers are accountable for defects, including inadequate warnings or faulty software in AI products.
Healthcare professionals can be liable for medical malpractice if they fail to critically evaluate AI recommendations, especially as these systems become the standard of care.
Healthcare organizations may be liable for failing to train professionals adequately, neglecting necessary updates and supports, or for not adopting beneficial AI technologies.
Potential harms include incorrect diagnoses, failure to provide timely treatment, adverse side effects from unnecessary procedures, and physical injury caused by malfunctioning AI systems.
Factors include the professional’s adherence to standard care practices, their choice of AI systems, and the adequacy of training and support provided regarding those systems.
Producers are responsible for ensuring safety, providing adequate warnings, conducting post-market monitoring, and addressing any design, manufacturing, or informational defects.
Patients can be deemed partially liable if they contribute to harm through improper data input or failure to comply with product instructions, affecting the assessment of negligence or contributory negligence.